Scientists at the Imperial College London in England have been awarded nearly £100,000, or about $125,000, by Parkinson’s UK to identify new therapeutic targets for Parkinson’s disease. The grant was awarded to Michael Johnson, PhD, and his team, and will fund efforts to harness the power of computers…

Parkinson’s UK is funding two new basic research projects at the University of Edinburgh, in Scotland, that have as their goal uncovering clues to the causes of Parkinson’s disease, with a focus on genetic involvement. According to the charity organization, such basic research provides the groundwork for understanding…

An informational podcast aims to instruct nursing students in Parkinson’s disease, helping them to feel more empathy for patients and equipping them with the knowledge needed for better Parkinson’s-specific care, a study reports. “By raising awareness of the disease, student nurses will develop an increased understanding, enabling them to…

The COVID-19 pandemic has had some negative physical and social impacts on the overall well-being of people with Parkinson’s disease, a new study highlights. Therefore, it’s important for clinicians to help patients get social support, not just address physical symptoms of the disease as pandemic-related restrictions ease, researchers wrote…

Enterin has teamed with Parkinson’s UK to launch a Phase 2 trial evaluating the ability of ENT-01, its investigational compound, to lessen Parkinson’s disease-associated dementia. The clinical trial will be led by Parkinson’s Virtual Biotech, the treatment development arm of Parkinson’s UK, and will be conducted at…

Two nonprofits have joined in an international partnership to accelerate the development of therapies for Parkinson’s disease (PD), a neurodegenerative condition thought to affect 10 million people globally. The Parkinson’s Foundation will invest at least $3 million over the next three years in Parkinson’s Virtual Biotech, the treatment development arm…

NRG Therapeutics has received a £2.68M (about $3.4 million) award to support preclinical work into small molecule disease-modifying therapies for neurodegenerative conditions such as Parkinson’s disease. The two-year Biomedical Catalyst award given the company is for early stage research in treatments to protect mitochondria in the brain, and is partly funded…

A new app called NMS Assist, designed to remotely monitor the non-motor symptoms of Parkinson’s disease, is being developed and tested by researchers at Plymouth University in the U.K. The goal is to offer an application that can track non-motor symptoms — cognitive problems, mood changes, and fatigue,…

In 1817, James Parkinson published “An Essay on the Shaking Palsy,” the first such recognition of a disease that eventually would be known by his name. On April 11, World Parkinson’s Day and the 267th anniversary of Parkinson’s birth, and throughout the month, the Parkinson’s community will raise awareness about…

Based on survey results indicating that pandemic restrictions considerably aggravated Parkinson’s disease (PD) symptoms and hampered care, Parkinson’s UK is calling on its various governments to take remedial steps to improve both care and access. Calls for action derive from a 41-page report by the nonprofit organization and Lancaster…